CSN Login
Members Online: 1

new drug may be usefull

Posts: 507
Joined: Apr 2010

I am a thyroid cancer survivor but found this and figured it might be important to you on this site

Aug. 17, 2011 -- The FDA today approved Zelboraf, a drug that can extend survival for the 50% of melanoma patients whose tumors carry the BRAF V600E mutation.


dearfoam's picture
Posts: 82
Joined: Apr 2011

Dad's onc just sent sample off to be tested for this mutation. We should know by the end of next week or so, and if he has it, hopefully he will be able to get patient assistance with the cost. He's stage 4 with multiple mets including brain.

Subscribe with RSS
About Cancer Society

The content on this site is for informational purposes only. It is not a substitute for professional medical advice. Do not use this information to diagnose or treat a health problem or disease without consulting with a qualified healthcare provider. Please consult your healthcare provider with any questions or concerns you may have regarding your condition. Use of this online service is subject to the disclaimer and the terms and conditions.

Copyright 2000-2015 © Cancer Survivors Network